首页> 美国卫生研究院文献>Cell Cycle >BRG1 the ATPase subunit of SWI/SNF chromatin remodeling complex interacts with HDAC2 to modulate telomerase expression in human cancer cells
【2h】

BRG1 the ATPase subunit of SWI/SNF chromatin remodeling complex interacts with HDAC2 to modulate telomerase expression in human cancer cells

机译:BRG1SWI / SNF染色质重塑复合体的ATPase亚基与HDAC2相互作用以调节人类癌细胞中的端粒酶表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Telomerase is often upregulated during initiation and/or progression of human tumors, suggesting that repression of telomerase might inhibit cancer growth or progression. Here, we report that BRG1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is a general suppressor of hTERT transcription in human cancer cells. While overexpression of BRG1 inhibits hTERT transcription, depletion of BRG1 stimulates transcription of hTERT, leading to higher telomerase activity and longer telomeres. Chromatin-immunoprecipitation assays revealed that BRG1 binds to the transcription start site (TSS) of the hTERT promoter and forms a ternary complex with histone deacetylase 2 (HDAC2). BRG1 remodels chromatin structure to facilitate the action of HDAC2, leading to deacetylation of H3K9ac and H4ac at the TSS and suppression of hTERT transcription. On the other hand, β-catenin binds to the TSS and stimulates hTERT transcription. Thus, BRG1/HDAC2 and β-catenin constitute a manipulative apparatus at the TSS to play opposite but complementary roles in regulating hTERT expression. These results uncover a yin-yang mechanism in modulating hTERT transcription and provide explanation for limited transcription of hTERT in human cancer cells. BRG1/HDAC2 may have a potential as an anti-cancer therapeutic and/or for reactivating cellular proliferative capacity in the context of in vitro tissue engineering.
机译:端粒酶通常在人类肿瘤的发生和/或进展过程中被上调,这表明端粒酶的抑制可能抑制癌症的生长或进展。在这里,我们报道BRG1,SWI / SNF染色质重塑复合体的ATPase亚基,是人类癌细胞中hTERT转录的一般抑制因子。虽然BRG1的过度表达抑制hTERT转录,但BRG1的耗尽会刺激hTERT的转录,从而导致更高的端粒酶活性和更长的端粒。染色质免疫沉淀试验表明,BRG1与hTERT启动子的转录起始位点(TSS)结合,并与组蛋白脱乙酰基酶2(HDAC2)形成三元复合物。 BRG1重塑染色质结构,以促进HDAC2的作用,导致H3K9ac和H4ac在TSS处脱乙酰化并抑制hTERT转录。另一方面,β-连环蛋白与TSS结合并刺激hTERT转录。因此,BRG1 / HDAC2和β-catenin在TSS处构成操纵装置,在调节hTERT表达中起相反但互补的作用。这些结果揭示了调节hTERT转录的阴阳机制,并为人类癌细胞中hTERT的有限转录提供了解释。在体外组织工程中,BRG1 / HDAC2具有潜在的抗癌治疗作用和/或重新激活细胞增殖能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号